Financial News
Ocugen Inc (NQ: OCGN )
1.300
+0.030
(+2.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Headline News about Ocugen Inc
![](https://g.foolcdn.com/editorial/images/643413/vaccine-being-given-to-young-woman-by-female-doctor.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/nio-stock-4.jpg)
I’d Take Nio Stock’s 12-Month Double Despite Falling Below $50
September 17, 2021
Via InvestorPlace
Topics
Electric Vehicles
Exposures
Electric Vehicles
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/coronavirus-vaccine.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/coronavirus-vaccine-2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_285.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/eye-691269_1920_15.jpg)
![](https://g.foolcdn.com/editorial/images/642928/gettyimages-1278800490-1.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/coronavirus-vaccine.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/covid-19_vaccine_image_by_wilfried_pohnke_from_pixabay__28.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_17.jpg)
![](https://investorplace.com/wp-content/uploads/2021/05/vaxart_vxrt_1600_e.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/vaccine-4892048_0.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600d.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/coronavirus-vaccine.jpg)
![](https://investorplace.com/wp-content/uploads/2020/09/biotech-stocks-300x169.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/coronavirus-vaccine.jpg)
![](https://investorplace.com/wp-content/uploads/2020/07/biopharma-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/coronavirus-vaccine.jpg)
![](https://g.foolcdn.com/editorial/images/640315/gettyimages-1266646735.jpg)
![](https://cdn.pixabay.com/photo/2020/03/25/11/34/syringe-4966959__340.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/coronavirus-vaccine.jpg)
![](https://cdn.pixabay.com/photo/2014/12/10/20/48/medic-563425_960_720.jpg)
Via Talk Markets
Exposures
Product Safety
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://investorplace.com/wp-content/uploads/2020/04/vaccine-2.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/coronavirus-vaccine.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_146.jpeg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/covid-19-vaccine-image_by_x3_from_pixabay_10.jpg)
Do mRNA COVID-19 Vaccines Cause Skin Or Kidney Disorders? EMA Investigates Possible Links
August 12, 2021
Via Benzinga
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.